A prospective phase II trial of the listeria-based human papillomavirus immunotherpay axalimogene filolisbac in second- and third-line metastatic cervical cancer: A NRG oncology group trial
Huh, W., Brady, W.E., Dizon, D.S., Powell, M.A., Landrum, L.M., Leath, C.A., Tanner, E.J., Higgins, R.V., Ueda, S.M., McHale, M.T., Aghajanian, C.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.506
Date:
June, 2017
File:
PDF, 50 KB
english, 2017